Quick Answer
Can-Fite BioPharma Ltd. reported Common Stock Shares Outstanding of 2.62 million shares for the year ending 2025.
- Can-Fite BioPharma Ltd. showed an increase of +163.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Can-Fite BioPharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Can-Fite BioPharma Ltd.'s Common Stock Shares Outstanding has declined by 97.8%.
- Historical annual values: Fiscal year 2025: 2.62 million shares | Fiscal year 2024: 994,394 shares | Fiscal year 2023: 1.36 billion shares | Fiscal year 2022: 815.75 million shares | Fiscal year 2021: 815.75 million shares | Fiscal year 2020: 463.77 million shares | Fiscal year 2019: 120.65 million shares.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: